Choreo, LLC Corcept Therapeutics Inc Transaction History
Choreo, LLC
- $7.23 Billion
- Q2 2025
A detailed history of Choreo, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Choreo, LLC holds 4,095 shares of CORT stock, worth $295,904. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,095
Previous 4,384
6.59%
Holding current value
$295,904
Previous $500,000
40.0%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding CORT
# of Institutions
479Shares Held
83.4MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.2 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$700 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$558 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$453 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$280 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.74B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...